Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Aug 9, 2021Company to host conference call and webcast 8:30 am ET
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the second quarter ended June 30, 2021 on Monday,...
Aug 4, 2021Contract adds to significant growth in the employer market for new behavioral health solutionDarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it has been selected as the digital behavioral health provider by a leading national...
- Jul 27, 2021New Relationship Expands Dario's Global Reach Across Full Suite of Digital Health Solutions
DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, today announced the launch of its digital behavioral health solution that now includes Workplace Options...
- Jul 20, 2021Nationally recognized Primary Care Medical Home becomes latest provider to join growing Dario RPM business
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it has been selected as a digital health provider by Alabama Regional Medical Services...
- Jul 13, 2021Conference brings together leaders in digital therapeutics to share learnings and promote the success of innovative technology
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced Chief Medical Officer Omar Manejwala, M.D. will present "Rebalancing: Digital Therapeutics in...
- Jul 12, 2021Demonstrates robust demand in the employer market
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced the launch of three new employer client contracts, including one global partnership, for...
- Jun 29, 2021New study presented at the American Diabetes Association 81st Scientific Sessions
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, presented new clinical research today at the American Diabetes Association (ADA) 81st Scientific...
- Jun 24, 2021Selection follows thorough evaluation of multiple competitive offerings
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it has been selected as digital health provider by Coastal Family Health Center, a local,...
- Jun 16, 2021New biofeedback sensor improves access to back health solutions and is aimed at increasing membership on Dario's integrated personalization platform
DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, announced today the launch of the Upright GO S, a new wearable sensor based on the company's pioneering...
- Jun 15, 2021
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it is set to join the broad-market Russell 3000® Index and the small-cap Russell 2000®...
- Jun 8, 2021
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, today announced the consummation of the previously announced acquisition of PsyInnovations, Inc. (dba...
- Jun 4, 2021
Study results to be presented at the 14th International Conference on Advanced Technologies and Treatments for Diabetes NEW YORK, June 4, 2021 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a...
- Jun 3, 2021
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the company plans to participate in the upcoming Stifel 2021 Virtual Cross Sector...
- May 27, 2021New Results Further confirm the Relationship Between Personalization and Outcomes
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced the publication of a new study through a Letter to the Editor in the Journal of Diabetes...
- May 26, 2021DarioHealth to Participate in the Virtual 18th Annual Craig-Hallum Institutional Investor Conference
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that management will participate in the 18th Annual Craig-Hallum Institutional Investor...
- May 18, 2021Expands Digital Chronic Care Platform to One of the Most Complete in the Industry
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it has entered into an agreement to acquire PsyInnovations, Inc. (dba wayForward), a...
- May 17, 2021Maintained momentum across all three pillars of long term strategic operating plan
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the first quarter of 2021 and provided a corporate and commercial...
- May 10, 2021Results will be published after market close
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the first quarter ended March 31, 2021 on Monday,...
- May 6, 2021Rick Anderson to Discuss the Role of Digital Health to Manage Chronic Diseases Alongside Global Luminaries Gathered to Explore the Latest Breakthroughs in Medicine, Health Care and Prevention
DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that Rick Anderson, President and General Manager of North America, will participate in...
- Apr 20, 2021DarioHealth will Provide Remote Patient Monitoring Services to MediOrbis for New Offering to Medicare Patients with Diabetes
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced today the launch of a new virtual care initiative with MediOrbis, a telehealth provider...
- Mar 9, 2021Significant progress across all pillars of long term strategic operating plan
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the fourth quarter and full year 2020 and provided a corporate and...
- Mar 5, 2021
DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the company will participate in the upcoming Stephens 2021 Best Ideas Conference...
- Mar 2, 2021Clinical Study Shows Increased Digital Engagement Resulted in 43% Improvement in Blood Glucose Levels
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, today announced the results of a new clinical study that have been published in the Journal of Medical...
-
Mar 1, 2021Company to host conference call and webcast 8:30 am ET
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the fourth quarter and full year ended December...
- Feb 23, 2021
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the company plans to participate in the upcoming Cowen 41st Annual Health Care...